Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-23 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Option exercise · Restricted Stock Units −7,012 21,033
2025-02-23 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise +6,688 35,501
2025-02-23 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −3,601 $57.75 $208K 31,900
2025-02-23 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Option exercise · Restricted Stock Units −6,688 20,063
2025-02-23 Torley Helen PRESIDENT AND CEO Option exercise +22,436 745,800
2025-02-23 Torley Helen PRESIDENT AND CEO Shares withheld for taxes −12,081 $57.75 $698K 733,719
2025-02-23 Torley Helen PRESIDENT AND CEO Option exercise · Restricted Stock Units −22,436 67,308
2025-02-20 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Grant or award · Option to Purchase Common Stock +11,902 11,902
2025-02-20 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Grant or award · Restricted Stock Units +11,230 11,230
2025-02-20 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Grant or award · Option to Purchase Common Stock +22,603 22,603
2025-02-20 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Grant or award · Restricted Stock Units +21,327 21,327
2025-02-20 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Grant or award · Option to Purchase Common Stock +22,603 22,603
2025-02-20 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Grant or award · Restricted Stock Units +21,327 21,327
2025-02-20 Torley Helen PRESIDENT AND CEO Grant or award · Option to Purchase Common Stock +71,038 71,038
2025-02-20 Torley Helen PRESIDENT AND CEO Grant or award · Restricted Stock Units +67,027 67,027
2025-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Option exercise +20,891 196,729
2025-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Shares withheld for taxes −8,721 $58.29 $508K 188,008
2025-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Option exercise +6,112 194,120
2025-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Shares withheld for taxes −3,103 $58.29 $181K 191,017
2025-02-16 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Option exercise +4,263 195,280

Page 20 of 26 · 513 trades